ACAD News

Latest breaking news and updates for ACAD stock.

Track all markets on TradingView

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on August 5, 2025, the Compensation Committee of Acadia’s Board of Directors (the “Committee”) granted in...

What is the potential impact of these grants on short‑term trading volume and volatility around the announcement? Will the new hires be filling critical roles that could impact the company's pipeline or partnership opportunities? How might the additional compensation expense be reflected in the next quarterly earnings guidance?
Compensation
20 days ago
Read more businesswire

Acadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2025. “Acadia continued to build momentum in the s...

What is the current share float and institutional ownership, and are there any notable shifts in insider or hedge fund activity following the release? How did the change in foreign exchange rates affect the reported revenue and how might future currency fluctuations impact future results? What were the net patient count and the average selling price (ASP) trends for NUPLAZID in the quarter?
Earnings
25 days ago
Read more businesswire

Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 45th Annual Growth Conference on Wednesday, A...

What risk factors should traders monitor in the days following the conference in case the messaging deviates from market expectations? How might the archived recording availability for a month influence ongoing analyst coverage and analyst consensus revisions? Are there any regulatory or safety updates in the pipeline that might be hinted at during the webcast?
Update
26 days ago
Read more businesswire

Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Scott Cenci as Senior Vice President, Chief Information and Data Officer. In this role, Sco...

Will the digital initiatives potentially create new data assets or intellectual property that could enhance the company’s long‑term valuation? What is the market’s perception of the senior leadership addition and how is it reflected in current analyst sentiment toward ACAD? Could the appointment lead to strategic partnerships or collaborations that might boost future revenues?
Leadership
27 days ago
Read more businesswire